Remmel H. Lawrence

Remmel H. Lawrence is listed in filings as Director at Atossa Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including purchase activity. Recent filings connect the profile to Atossa Therapeutics, Inc. (ATOS). The current snapshot covers public activity from Jul 1, 2024 to May 14, 2026. Reported amounts are shown as $123.8K to $131.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.